Stockholm3 blood test detected 90% of aggressive prostate cancer cases compared to 74% for PSA tests in a study of over 12,000 men in Sweden.

A new study suggests the investigational Stockholm3 blood test may improve the early detection of aggressive prostate cancer compared with the standard PSA test.

Prostate cancer is still among the most prevalent cancers of men globally, but timely detection is everything. Over recent years, medical professionals have been emphasizing the key role of a simple ...

Black men are much more likely to die from prostate cancer than the general population. A group of Chicago-area researchers ...

Blood tests to detect potential signs of prostate cancer likely reduce the risk of dying from prostate cancer, an updated Cochrane review finds. This is a shift from the previous version of the review ...

The Stockholm3 model combines PSA, plasma protein biomarkers, polygenic risk, and clinical factors for prostate cancer screening.

A large analysis suggests that a multivariable risk assessment tool, called Stockholm3, can detect substantially more ...

New technologies can potentially save lives by helping identify prostate cancer earlier, and transforming the way doctors ...

Researchers at the Johns Hopkins Kimmel Cancer Center, Johns Hopkins All Children's Hospital and four other institutions have devised a novel method to test for prostate cancer using biomarkers ...

Sponsor activations are common in auto racing and all modern sports. This one, however, could literally save lives.

The study's testing accurately identified prostate cancer 91% of the time and accurately ruled out men without prostate cancer 84% of the time. A urine-based biomarker panel may be a promising, ...